Showing results (81-90 of 133) with videos related to
Sort By:
Pageof 14
Journal of Diabetes Science and Technology|August 12, 2024
How to Use Continuous Glucose Monitoring Efficiently in Diabetes Management: Opinions and Recommendations by German Experts on the Status and Open QuestionsAndreas Thomas, Thomas Haak, Astrid Tombek, et al.Diabetes Care|April 27, 2022
The Importance of Office Blood Pressure Measurement Frequency and Methodology in Evaluating the Prevalence of Hypertension in Children and Adolescents With Type 1 Diabetes: The SWEET International DatabaseAndriani Vazeou, Sascha R Tittel, Niels H Birkebaek, et al.Diabetes Care|May 24, 2011
Diabetes and neurodegeneration in Wolfram syndrome: a multicenter study of phenotype and genotypeJulia Rohayem, Christian Ehlers, Bärbel Wiedemann, et al.Journal of Clinical Lipidology|May 31, 2023
Prevalence of LDL-hypercholesterolemia and other cardiovascular risk factors in young people with type 1 diabetesIrena Drozd, Jantje Weiskorn, Karin Lange, et al.Journal of Diabetes Research|November 20, 2015
Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4)Claudia Ziegler, Alon Liberman, Revital Nimri, et al.Diabetes, Obesity & Metabolism|November 20, 2020
Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream studyTorben Biester, Ido Muller, Thekla von dem Berge, et al.Diabetes, Obesity & Metabolism|December 17, 2016
MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trialRevital Nimri, Natasa Bratina, Olga Kordonouri, et al.Diabetes, Obesity & Metabolism|November 28, 2018
DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at homeTorben Biester, Judith Nir, Kerstin Remus, et al.Journal of Autoimmunity|August 1, 2025
Epigenetic differences at immune and type 1 diabetes susceptibility genes in blood from young children after COVID-19 infectionRaffael Ott, Tarini Singh, Katharina Schütte-Borkovec, et al.Nutrients|July 14, 2023
Alterations in Dietary Behavior, Appetite Regulation, and Health-Related Quality of Life in Youth with Obesity in Germany during the COVID-19 PandemicNora Struckmeyer, Torben Biester, Olga Kordonouri, et al.Pageof 14